|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||22.55 mL||112.74 mL||225.48 mL|
|0.5 mM||4.51 mL||22.55 mL||45.1 mL|
|1 mM||2.25 mL||11.27 mL||22.55 mL|
|5 mM||0.45 mL||2.25 mL||4.51 mL|
*The above data is based on the productmolecular weight 443.49. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
|Synonyms||E 3810, E3810, Lucitanib|
Vandetanib (Zactima) is a VEGFR and EGFR antagonist and a tyrosine kinase inhibitor with IC50 of 60, 90, 40 nM for HUVEC proliferation, PC-9…
AZD4547 is a potent, selective and orally active pan-FGFR inhibitor, with IC50s of 0.2, 2.5, 1.8 and 165 nM for FGFR1, 2, 3 and 4, respectiv…
ZM 306416 is a VEGF receptor tyrosine kinase inhibitor that inhibits KDR (IC50 = 100 nM) and Flt (IC50 = 2 uM) tyrosine kinases.
BLU9931 is the first selective small molecule inhibitor of FGFR4 with IC50 of 3 nM; less potent for FGFR1/2/3(IC50> 150 nM),
PD173074 is a potent, cell permeable and ATP competitive inhibitor of FGFR and VEGFR.
Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit th…
SU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-d…